Jind is a high-stakes poll battle being dubbed as a semifinal in Haryana, in which Congress' Surjewala, newly formed JJP, apart from BJP and INLD are in the fray.
Advice comes at a time when India accounts for a 5th of global generic drug supply & 40% of generics used in US. However, this strength in finished formulations relies on imported ingredients.
It’s easy to understand why the government can’t speak the hard truth. When this war ends, as all wars do, India’s interests will lie with both the winner and the loser.
COMMENTS